Tom Cech

As part of BioFrontiers Institute Professor John Rinn’s biochemistry class, this week graduate students performed an RNA splicing interpretive dance on the west lawn of the Jennie Smoly Caruthers Biotech Building. CU Nobel Laureate and BioFrontiers Director Tom Cech (in the tie-dye T-shirt) played the starring role of the catalytic...

After years of companies being sold off or growing and relocating, Boulder’s life-sciences sector is showing signs of reaching critical mass. Companies such as Clovis Oncology Inc. (Nasdaq: CLVS), SomaLogic Inc., Array Biopharma Inc. (Nasdaq: ARRY) and miRagen Therapeutics Inc. (Nasdaq: MGEN) are showing that homegrown businesses can continue to...

Nobel Laureate Professor Tom Cech came to the Department of Chemistry on 16th October, to give the 2017 Herchel Smith Lecture: 'Shedding some Light on the Dark Matter of the Genomic Universe.' Professor Cech is Distinguished Professor at the University of Colorado Boulder, Director of the University of Colorado BioFrontiers...

University of Colorado Boulder Distinguished Professor Tom Cech, Colorado’s first Nobel Prize winner, has been named the 2017 Hazel Barnes Prize winner – the most distinguished award a faculty member can receive from the university. Cech, the director of the BioFrontiers Institute , shared the 1989 Nobel Prize in Chemistry...

A deep look inside the live cells reveals a key cancer process Telomerase, a powerful enzyme found at the ends of chromosomes, can keep humans healthy, or promote cancer growth. Researchers at the University of Colorado in Boulder used a process called single-molecule imaging to look into the complicated processes...

John Milligan spent two years at the University of Colorado Boulder during his graduate studies in the mid-1980’s. He helped to move his mentor, Dr. Olke Uhlenbeck, in a U-Haul truck across the Great Plains to the Rockies. Uhlenbeck was recruited from the University of Illinois in 1986 to head...

Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. In 1997, scientists discovered a gene that they believed was the key to cellular...

In a new paper released today in Nature , BioFrontiers Institute scientists at the University of Colorado in Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development that is sitting at the ends of our DNA. Researchers in the two scientists’ laboratories collaborated to find...

BioFrontiers Director attends Senate Forum September’s first meeting of the Science, Technology and Policy Forum was held to zero in on a discussion of the human genome and its implications for medicine. Attendees included Dr. Ralph Cicerone, President of the National Academy of Sciences, Dr. Bruce Beutler (awarded the 2011...

We rank the Mile High City's most influential powerbrokers in our primer on who's running Denver. 39. Tom Cech/Leslie Leinwand Directors, Colorado Initiative in Molecular Biology Behind Leinwand and Cech, the latter of whom won the Nobel Prize for chemistry in 1989, this interdisciplinary research center at CU-Boulder is developing...